Cited by 15Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatmentsCancer-related cognitive impairment studies

Correction: Ushering in the study and treatment of preclinical Alzheimer disease

Open access
J. B., Langbaum·2013·Nature Reviews Neurology

Integrity signals

Registry

Crossref · 10.1038/nrneurol.2013.145

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Current established methods for biological assessment of AD progression include structural MRI, FDG-PET, amyloid PET, and CSF sampling.

    “Currently the most established methods for the biological assessment of disease progression in patients are estimation of regional brain atrophy using structural MRI, PET imaging of glucose metabolism using fluorodeoxyglucose (FDG) and imaging of amyloid deposits (e.g. using [11C]-PIB or [18F]-Florbetapir) as well as invasive CSF sampling to measure tau and amyloid moieties (Langbaum et al., 2013)”

    From In vivo imaging of tau pathology using multi-parametric quantitative MRI (2015) · cites this paper as Langbaum et al., 2013

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
J. B., L.
Venue
Nature Reviews Neurology
Published
2013-07-16
Volume
9
Issue
8
Pages
418-418
ISSN
  • 1759-4758 (ISSN-L)
  • 1759-4766
OpenAlex
W2783011569
Cited by
15
References
1
Citations by year
2018: 1 · 2016: 2 · 2015: 3 · 2014: 6 · 2013: 3
Type
journal article
Language
en
Open access
Locations
Nature Reviews Neurology (publishedVersion)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Cancer-related cognitive impairment studies
Keywords
preclinical Alzheimer's disease, at-risk individuals, Alzheimer's disease diagnosis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review